• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

adhd medication pregnancy Medication During Pregnancy and Breastfeeding

Women suffering from ADHD face a difficult decision regarding whether or not to stop taking ADHD medication during pregnancy and breastfeeding. There are few data regarding how exposure over time may affect the pregnant fetus.

A recent study published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological issues such as hearing loss or vision, febrile seizures, or IQ impairment. The authors acknowledge that further high-quality studies are required.

Risk/Benefit Analysis

Pregnant women who use ADHD medications need to balance the advantages of using them against the risks to the fetus. Physicians don't have the data needed to provide clear recommendations however they can provide information regarding the risks and benefits to aid pregnant women in making informed choices.

A study published in Molecular Psychiatry concluded that women who were taking ADHD medication during their early pregnancy were not at a higher risk of fetal malformations or structural birth defects. The researchers used a large, population-based case-control study to evaluate the incidence of major structural birth defects in babies born to mothers who had taken stimulants in the early stages of pregnancy and those who had not. Pediatric cardiologists, clinical geneticists and other experts examined the cases to make sure that the classification was correct and to reduce any bias.

However, the study had its limitations. The researchers were unable, in the first place to distinguish the effects triggered by the medication from the disorder. This makes it difficult for researchers to determine whether the small associations observed among the groups exposed were due to medication use, or if they were affected by comorbidities. Additionally the study did not look at the long-term outcomes of offspring.

The study found that infants whose mother took ADHD medication during pregnancy had a higher chance of being admitted to the neonatal care unit (NICU), compared to mothers who did not use any medication during pregnancy, or had discontinued taking their medication prior to or during pregnancy. The reason for this was central nervous system disorders. The higher risk of admission was not influenced by the stimulant medications used during pregnancy.

Women who took stimulant ADHD medications during pregnancy also had a higher chance of having a caesarean section or a baby that scored low on the Apgar scale (less than 7). These increases did appear to be unrelated to the type of medication taken during pregnancy.

The research suggests that the low risk associated with the use of adhd Medication Pregnancy medications during the early stages of pregnancy may be offset by the higher benefit to both mother and child of continuing treatment for the woman's disorder. Physicians should talk to their patients about this issue and try to help them develop coping skills that could reduce the impact of her disorder in her daily life and relationships.

Medication Interactions

As more women than ever before are being diagnosed with ADHD and being treated with medication, the issue of whether or not to discontinue treatment during pregnancy is a question that more and more doctors face. These decisions are often taken without clear and authoritative evidence. Instead, doctors have to consider their own expertise and experience, as well as the experiences of other doctors, and the research on the subject.

In particular, the issue of potential risks to the baby can be a challenge. Many of the studies on this subject are based on observations instead of controlled research and their findings are often contradictory. Furthermore, most studies restrict their analysis to live births, which may underestimate the severity of teratogenic effects that could result in abortion or termination of the pregnancy. The study discussed in this journal club addresses these issues by analyzing data on live and deceased births.

The conclusion The conclusion: While certain studies have demonstrated that there is a positive correlation between ADHD medications and the possibility of certain birth defects, others have found no connection, and most studies have a neutral or slightly negative impact. In all cases it is imperative to conduct a thorough study of the risks and benefits is required.

For a lot of women with ADHD, the decision to stop taking medication is difficult if not impossible. In fact, in an article recently published in Archives of Women's Mental Health psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can cause depression, feelings of isolation and family conflict for patients with ADHD. Additionally, the loss of medication can affect the ability to perform jobs and drive safely that are crucial aspects of a normal life for many people suffering from treating adhd without medication.

She recommends that women who are unsure about whether or not to stop taking medication because of their pregnancy consider informing family members, friends and colleagues on the condition, its effects on daily functioning, and on the benefits of keeping the current treatment plan. It can also help women feel supported in her decision. Some medications can pass through the placenta. If a woman decides to stop taking her ADHD medication while breastfeeding, it is important to be aware that the medication could be transferred to the baby.

Birth Defects and Risk of

As the use and use of ADHD medication to treat symptoms of attention deficit hyperactivity disorder (strattera adhd medication) is increasing the concern over the potential adverse effects of the drugs on the fetuses. Recent research published in the journal Molecular Psychiatry has added to the body of knowledge on this issue. With two massive data sets researchers were able to analyze more than 4.3 million pregnancies and determine whether the use of stimulant medications increased the risk of birth defects. Although the risk overall remains low, the scientists discovered that the first-trimester exposure to ADHD medications was associated with an increase in the risk of certain heart defects, such as ventriculoseptal defect (VSD).

The researchers of the study found no link between early medication use and other congenital abnormalities, such as facial clefting or club foot. The results are consistent with previous studies showing the presence of a small, but significant increase in the risk of developing cardiac malformations among women who began taking ADHD medications prior to the time of pregnancy. This risk increased during the latter part of pregnancy, when a lot of women began to stop taking their medication.

Women who took ADHD medications during the first trimester of their pregnancy were also more likely to undergo caesarean section, low Apgar score following delivery, and a baby who needed breathing assistance at birth. The authors of the study could not eliminate bias due to selection because they limited their study to women without other medical conditions that might have contributed to the findings.

Researchers hope that their research will inform physicians when they meet pregnant women. The researchers suggest that while discussing risks and benefits are crucial, the decision regarding whether or not to stop taking medication should be according to the severity of each woman's ADHD symptoms and her requirements.

The authors also advise that, while stopping the medication is an alternative, it is not a recommended practice because of the high incidence of depression and other mental health issues for women who are expecting or recently postpartum. Additionally, the research suggests that women who decide to stop taking their medications are more likely to have difficulties adapting to life without them after the birth of their baby.

Nursing

The responsibilities that come with being a new mom can be overwhelming. Women who suffer from ADHD may face a lot of challenges when they must manage their symptoms, go to doctor appointments and prepare for the birth of a child and adjust to a new routine. This is why many women choose to continue taking their ADHD medication throughout the pregnancy.

The majority of stimulant medications are absorbed through breast milk in very small quantities, so the risk to the infant who is breastfeeding is low. However, the amount of exposure to medications by the infant can differ based on dosage, frequency it is administered and the time of day the medication is administered. Additionally, individual medications enter the body of the baby differently through the gastrointestinal tract and breast milk and the impact of this on a newborn is not fully understood.

Due to the absence of research, some physicians might be tempted to stop taking stimulant medication during the pregnancy of a woman. This is a difficult decision for the woman who must weigh the benefits of her medication against the risk to the fetus. Until more information is available, GPs should ask all pregnant patients about their history of adhd depression medication and whether they are taking or planning to take medication during the perinatal time.

Many studies have shown that women can continue taking their ADHD medication without risk during pregnancy and breast-feeding. This has led to many patients are choosing to do so and in consultation with their physician, they have found that the benefits of maintaining their current medication far exceed any risk.

It is essential for women with ADHD who are considering breastfeeding to seek a specialist psychiatrist's guidance prior to becoming pregnant. They should review their medications with their doctor and discuss the advantages and disadvantages of continuing treatment, including non-pharmacological strategies. Psychoeducation is also required to help pregnant women with adhd medication uk for adults recognize the signs and underlying disorder. They should also be informed about treatment options and build strategies for coping. This should be a multidisciplinary approach together with obstetricians, GPs, and psychiatry. Counselling for pregnancy should include discussion of a management plan for both the mother and child, as well as monitoring for signs of deterioration, and the need for adjustments to the medication regimen.